Cure for increasing health care costs: The Bernhoven case as driver of new standards of appropriate care.


Journal

Health policy (Amsterdam, Netherlands)
ISSN: 1872-6054
Titre abrégé: Health Policy
Pays: Ireland
ID NLM: 8409431

Informations de publication

Date de publication:
03 2019
Historique:
received: 25 07 2017
revised: 03 01 2019
accepted: 06 01 2019
pubmed: 28 1 2019
medline: 16 7 2020
entrez: 28 1 2019
Statut: ppublish

Résumé

Containing costs is a major challenge in health care. Cost and quality are often seen as trade-offs, but high quality and low costs can go hand-in-hand as waste exists in unnecessary and unfounded care. In the Netherlands, two healthcare insurers and a hospital collaborate to improve quality of care and decrease healthcare costs. Their aim is to reduce unnecessary care by shifting the business model and culture from a focus on volume to a focus on quality. Key drivers to support this are taking time for integrated diagnosis ('first time right'), the right care at the right place and shared decision making between doctor and patient. Conditions to realize this are 1) contract innovation between the hospital and insurers to move away from fee-for-service reimbursement, 2) a culture change within the organization with emphasis on collaboration and empowerment of medical leadership and physicians to change daily practice, and 3) a reorganization of the hospital organization structure from a large number of medical departments to four business units related to the fundamental underlying patient need (acute care, solution shop, intervention unit and chronic care). Results from this whole-system-approach experiment show it is possible to provide better care (as experienced by patients) with lower volumes (16% lower DRG claims after 3 years) and provides valuable lessons for further healthcare reform.

Identifiants

pubmed: 30685212
pii: S0168-8510(19)30002-8
doi: 10.1016/j.healthpol.2019.01.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

306-311

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Nicoline van Leersum (N)

Dutch Institute for Clinical Auditing, Department of innovation, Rijnsburgerweg 10, 2333AA Leiden, the Netherlands.

Peter Bennemeer (P)

Bernhoven Hospital, Nistelrodeseweg 10, 5407 PT Uden, the Netherlands.

Marcel Otten (M)

PwC Strategy& (Formerly Booz&co), Thomas R. Malthusstraat 5, 1066 JR Amsterdam, the Netherlands. Electronic address: marcel.otten@strategyand.nl.pwc.com.

Sander Visser (S)

PwC Strategy& (Formerly Booz&co), Thomas R. Malthusstraat 5, 1066 JR Amsterdam, the Netherlands.

Ab Klink (A)

VGZ, Stationsstraat 12, 6811 KS Arnhem, the Netherlands.

Jan A M Kremer (JAM)

PwC Strategy& (Formerly Booz&co), Thomas R. Malthusstraat 5, 1066 JR Amsterdam, the Netherlands; Radboud University Nijmegen Medical Center, Scientific Institute for Quality of Healthcare, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH